Skip to main content

Tagged With "white blood cells"

Blog Post

Teva Announces Two More Digital Inhalers for Asthma - AirDuo® Digihaler® and ArmonAir® Digihaler®

AAFA Community Services ·
Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of AirDuo® Digihaler® (fluticasone propionate and salmeterol) inhalation powder and ArmonAir® Digihaler® (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma. AirDuo® Digihaler® is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older.
Comment

Re: Living With Eczema: Raise Awareness By Telling Your Eczema Story

Tyler Corella ·
I’ve suffered from eczema, along with asthma for my entire life due to extreme prematurity. I’ve always found it to be quite a nuisance, but especially more so once I entered HighSchool. I mainly suffer with eczema on my arms and legs. It took going through so many different medications to find what didn’t burn my skin, or make it itch a thousand times worse, and as a young kid, that impulse control was non-existent to the point where my arms would be cracked with blood. Luckily, it’s gotten...
Blog Post

Leading Patient Advocacy Organizations Join Forces to Launch National Program Aimed at Raising Awareness of Severe Form of Asthma

AAFA Community Services ·
Allergy & Asthma Network (AAN) and the Asthma and Allergy Foundation of America (AAFA) today announced the launch of Be the Boss of Your Asthma, a national educational program that aims to raise awareness of severe eosinophilic asthma – or S.E.A. – a serious and often hard-to-control form of asthma.
Blog Post Featured

Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

AAFA Community Services ·
On Dec. 3, 2020, the National Institutes of Health (NIH) announced updates to the clinical guidelines used to diagnose and manage asthma. The new guidelines are titled "The 2020 Focused Updates to the Asthma Management Guidelines: A Report from The National Asthma Education and Prevention Program Expert Panel Working Group." The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, oversaw the National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) and...
Blog Post

Town Hall: Black Americans and the COVID-19 Vaccine

AAFA Community Services ·
The COVID-19 pandemic has hit Black Americans hard. According to The COVID Racial Data Tracker , the COVID death rate of Black Americans is 1.5 times that of white people. We now have two COVID-19 vaccines , with more on the way. While the vaccines offer hope overall, they raise other concerns. Many Black Americans may not be able to get it. Or they may choose to not to get it. The National Minority Quality Forum (NMQF) held a virtual town hall on Jan. 25, 2021, to examine barriers that may...
Comment

Re: Generic Montelukast and Singulair Will Now Carry Stronger Warning Label About Possible Side Effects

Shea ·
KMC, My CSS was diagnosed after a medical crisis-- It was evening and I was struggling to breathe (not long after my ex dropped a bunch of my stuff that was covered in cat and dog dander off to the room I was staying in at my parents house) and I had moved out of his house because of my severe allergies (which seemed controlled with Singualair at first that is why I moved in there but after a year I had asthma symptoms and phlegm and kept needing to go to the ER for breathing treatments and...
Blog Post Featured

AAFA's Experts Help FDA and NIH Address Safety of Asthma Medications During Pregnancy and Lactation

AAFA Community Services ·
Asthma is one of the most common medical problems that occurs during pregnancy. It can be potentially serious. Asthma can get worse during pregnancy and lead to problems like high blood pressure, early labor and delivery, and low birth weight. Asthma can even cause death. The Centers for Disease Control and Prevention (CDC) tracks pregnancy-related deaths (from any cause) in the United States in a system called the Pregnancy Mortality Surveillance System (PMSS) . The rate of maternal deaths...
Blog Post

AAFA Teams With OMRON Healthcare to Provide Nebulizers to Vulnerable Patients With Asthma

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) is working with OMRON Healthcare to distribute medical-grade nebulizers and expand access to asthma management technology to underserved communities nationwide through AAFA's regional chapters . We appreciate Omron's support of AAFA's mission to address health disparities across the U.S . PRESS RELEASE OMRON Healthcare, Asthma and Allergy Foundation of America (AAFA) Join Together to Provide More Respiratory Medical Care to Underserved...
Blog Post

FDA Approves Xolair® (Omalizumab) Prefilled Syringe for Self-Injection

AAFA Community Services ·
Novartis today announced that the US Food and Drug Administration (FDA) approved the supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection in appropriate patients across all approved US indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.
Blog Post Featured

How Can You Tell the Difference Between COVID-19, a Cold, the Flu, Allergies and Asthma?

AAFA Community Services ·
Cold and flu season is here, and the new coronavirus that causes COVID-19 is still spreading. With every cough or sniffle, you may wonder if it’s asthma or allergies, the flu, the common cold or even COVID-19. But how can you tell the difference? The Asthma and Allergy Foundation of America (AAFA) has created a respiratory symptoms chart to help you recognize the difference between these conditions. Click to see larger image (English) Click to see larger image (Spanish) Asthma Symptoms...
Blog Post

Amgen Submits Biologics License Application for Tezepelumab for Severe Asthma

AAFA Community Services ·
Amgen today announced its partner AstraZeneca submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tezepelumab, a potential first-in-class medicine in severe asthma.
Blog Post

Dupixent® (Dupilumab) Improves Lung Function and Reduces Asthma Attacks in Children in Phase 3 of Clinical Trial

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) is sharing this press release to bring you the latest research news quickly. [PRESS RELEASE] Pivotal Data at ATS 2021 Show Dupixent® (dupilumab) Significantly Reduced Asthma Attacks and Improved Lung Function in Children Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma in a randomized Phase 3 trial, with potential to be best-in-class treatment for...
Blog Post

Asthma and Allergy Myths, Part 2! Home Allergy Tests, Caffeine, Adult Asthma, and Food Allergies and COVID-19 Vaccines

AAFA Community Services ·
Can caffeine stop an asthma attack? Are at-home food allergy tests legit? Dr. M. Itch is back on TikTok to answer these questions and more about asthma and allergies . Don't forget to check out our first round of myth-busting videos . Watch our AAFA blog and TikTok channel for more videos during National Asthma and Allergy Awareness Month . RELATED CONTENT Watch Dr. M. Itch bust more asthma and allergy myths: Part 1: Face Masks, Inhalers, and Climate Change Part 3: Food Allergies: Milk...
Blog Post

Managing Asthma in 2021 (Video and Resources)

AAFA Community Services ·
Update: If you missed the webinar, we added the video below. We also included some resources on additional information discussed in the webinar. Understanding the Latest Asthma Management Guidelines The Asthma and Allergy Foundation of America (AAFA) hosted a webinar on May 25, 2021, on the latest asthma management guidelines from the National Heart, Lung and Blood Institute (NHLBI). The webinar was presented by: John James, MD, board-certified allergist, President of Food Allergy Consulting...
Comment

Re: Coronavirus (COVID-19): What People With Asthma Need to Know

Tom Martin III ·
You better buy a proper mask Exposure to CO2 can produce a variety of health effects. These may include headaches, dizziness, restlessness, a tingling or pins or needles feeling, difficulty breathing, sweating, tiredness, increased heart rate, elevated blood pressure, coma, asphyxia, and convulsions... ask for 2020 certification when seeking IAQ and surface Protection...
Blog Post

Preparing for Natural Disasters When You Have Asthma

AAFA Community Services ·
If you have asthma, natural disasters could affect your health in unexpected ways. Chronic medical conditions like asthma can become worse when wildfires, tornadoes, severe flooding or earthquakes occur. Asthma flare-ups during a disaster can happen because of: Allergens in the air (pollen, mold, etc.) Irritants in the air (dust, smoke) Losing access to your treatments due to evacuation Strong emotions (fear, anxiety) Now is a good time to create a disaster planning kit with your asthma in...
Blog Post

What If You’re Allergic to Grass? 11 Steps to Managing Grass Pollen Allergy

AAFA Community Services ·
Grasses are one of the most common causes of allergy. Each year, plants (including grasses) release tiny pollen grains to fertilize other plants of the same species. Unfortunately for people with grass allergies, this pollen triggers allergic reactions.
Blog Post

Asthma and Pregnancy: Information to Help You and Your Baby

AAFA Community Services ·
Asthma is one of the most common medical concerns during pregnancy. If you are pregnant with asthma , here is some information to help you give your baby a better chance for a strong, healthy start. Your asthma symptoms may change during pregnancy. About 1/3 of pregnant woman have worse asthma symptoms. And another 1/3 see their asthma symptoms get better. Keep your asthma well-controlled to benefit both you and your baby. If you breathe better, your baby can get oxygen it needs from your...
Blog Post Featured

Brace Yourselves: The Biggest Week for Asthma Attacks Is Coming

AAFA Community Services ·
Every September, asthma hospitalizations rise. Doctors see more people with asthma episodes and attacks. The third week of the month is the worst. It is called the September Asthma Epidemic or Asthma Peak Week. Everyone with asthma needs to be prepared.
Blog Post

Sarah Michelle Gellar and Teva Team Up to Help People With Asthma and COPD Improve Inhaler Use

AAFA Community Services ·
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., today announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control. Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah Michelle Gellar, who will share her own experience living with asthma and encourage others to take control of their disease.
Blog Post

Dupixient® Now FDA Approved for Children Ages 6 to 11 Years With Moderate-to-Severe Asthma

AAFA Community Services ·
FDA Expands Approval of DUPIXENT® (DUPILUMAB) to Include Children Ages 6 to 11 Years With Moderate-to-Severe Asthma. Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option.
Blog Post Featured

Coronavirus (COVID-19): What People With Asthma Need to Know

AAFA Community Services ·
Updated 10/14: The coronavirus that causes COVID-19 is still highly active through the U.S. Read the current recommendations for people with asthma including symptoms, wearing masks, and guidelines if you're fully vaccinated.
×
×
×
×